Publication:
Sustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation

dc.contributor.authorNarawat Nuamnaichatien_US
dc.contributor.authorVilasinee Hirunpanich Satoen_US
dc.contributor.authorPrimchanien Moongkarndien_US
dc.contributor.authorWarisara Parichatikanonden_US
dc.contributor.authorSupachoke Mangmoolen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2019-08-23T10:38:19Z
dc.date.available2019-08-23T10:38:19Z
dc.date.issued2018-01-15en_US
dc.description.abstract© 2017 Elsevier Inc. Paracrine factors, including growth factors and cytokines, released from cardiac myocytes following β-adrenergic receptor (β-AR) stimulation regulate cardiac fibroblasts. Activated cardiac fibroblasts have the ability to increase collagen synthesis, cell proliferation and myofibroblast differentiation, leading to cardiac fibrosis. However, it is unknown which β-AR subtypes and signaling pathways mediate the upregulation of paracrine factors in cardiac myocytes. In this study, we demonstrated that sustained stimulation of β-ARs significantly induced synthesis and secretion of growth factors, including connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF), via the cAMP-dependent and protein kinase A (PKA)-dependent pathways. In addition, isoproterenol (ISO)-mediated synthesis and secretion of CTGF and VEGF through the β1-AR and β2-AR subtypes. Paracrine factors released by cardiac myocytes following sustained β-AR stimulation are necessary for the induction of cell proliferation and synthesis of collagen I, collagen III and α-smooth muscle actin (α-SMA) in cardiac fibroblasts, confirming that β-AR overstimulation of cardiac myocytes induces cardiac fibrosis by releasing several paracrine factors. These effects can be antagonized by β-blockers, including atenolol, metoprolol, and propranolol. Thus, the use of β-blockers may have beneficial effects on the treatment of myocardial fibrosis in patients with heart failure.en_US
dc.identifier.citationLife Sciences. Vol.193, (2018), 257-269en_US
dc.identifier.doi10.1016/j.lfs.2017.10.034en_US
dc.identifier.issn18790631en_US
dc.identifier.issn00243205en_US
dc.identifier.other2-s2.0-85032955306en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/45267
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85032955306&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleSustained β-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activationen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85032955306&origin=inwarden_US

Files

Collections